Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferiprone effect on nitric oxide production in thalassemia
TCTR20140807001Completed
- Sponsor
- Mahidol University
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of deferiprone in beta thalassemia and iron overload (2 arms), sponsored by Mahidol University. Primary endpoint: Nitric oxide levels in blood at 6 hours. Started Aug 2014; status: completed.
02
Drugs
deferiprone
03
Conditions
beta thalassemiairon overload
Beyond the preview
Go deeper on TCTR20140807001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20140807001.